Sorry a bit late here, but the numbers for CagriSema are actually not as good as Retatrutide's were. Unless I'm missing something:

Reta 8mg -22% body weight at 48 weeks

CagriSema -20.4% body weight at 68 weeks

CagriSema has been on my radar for a while, and it's certainly going to be exciting.

Here's a slightly better link for the curious:

https://pubmed.ncbi.nlm.nih.gov/40544433/

https://clinicaltrials.gov/study/NCT05567796